Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is N/A as of 2026-10-06T21:55:41.614Z.
Calculation as of: 2026-10-06T21:55:41.614Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a397cd850420951a0c9724a6b76f21fabdb26d17d869f1b33831b183cdf643d3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-08-26.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
N/A
EV/ASSETS RATIO AVG TTM
0.12x
EV/ASSETS RATIO AVG 3Y
N/A
EV/ASSETS RATIO AVG 5Y
N/A
EV/ASSETS RATIO AVG 10Y
N/A
EV/ASSETS RATIO AVG 15Y
N/A
EV/ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.88M
EV/Assets Ratio
N/A
TTM Avg
0.65x
3Y Avg
82.69x
5Y Avg
1751.25x
Market Cap
$1.84M
EV/Assets Ratio
0.59x
TTM Avg
0.40x
3Y Avg
0.28x
5Y Avg
0.68x
Market Cap
$1.83M
EV/Assets Ratio
14.51x
TTM Avg
97.45x
3Y Avg
111.64x
5Y Avg
111.64x
Market Cap
$1.81M
EV/Assets Ratio
1.11x
TTM Avg
1.54x
3Y Avg
1.16x
5Y Avg
1.56x
Market Cap
$2.14M
EV/Assets Ratio
0.52x
TTM Avg
0.91x
3Y Avg
1.03x
5Y Avg
0.90x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | $1.88M | N/A | 0.12x | N/A | N/A |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.88M | N/A | 0.65x | 82.69x | 1751.25x |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | 0.59x | 0.40x | 0.28x | 0.68x |
| Beyond Air, Inc. (XAIR)vs › | $1.84M | N/A | 0.68x | 0.71x | 1.34x |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.83M | 14.51x | 97.45x | 111.64x | 111.64x |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | 1.11x | 1.54x | 1.16x | 1.56x |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | N/A | 0.72x | 0.76x | 1.68x |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | N/A | 0.14x | 0.30x | 0.55x |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | 0.52x | 0.91x | 1.03x | 0.90x |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | N/A | 0.12x | 0.12x | 0.12x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-08-26 | 0.00x |
| 2026-08-25 | 0.11x |
| 2026-08-17 | 0.00x |
| 2026-08-14 | 0.07x |
| 2026-08-13 | 0.07x |
| 2026-08-04 | 0.47x |
| 2024-12-31 | 0.04x |
| 2024-12-30 | 0.09x |
| 2024-12-20 | 0.00x |
| 2024-12-06 | 0.08x |
| 2024-12-05 | 0.01x |
| 2024-12-04 | 0.06x |
| 2024-12-03 | 0.08x |
| 2024-12-02 | 0.19x |
| 2024-11-29 | 0.28x |
| 2024-11-27 | 0.41x |
| 2024-11-26 | 0.51x |
| 2024-11-25 | 0.58x |
| 2024-11-22 | 0.57x |
| 2024-11-21 | 2.11x |
| 2024-11-20 | 2.07x |
| 2024-11-19 | 2.04x |
| 2024-11-18 | 1.87x |
| 2024-11-15 | 1.71x |
| 2024-11-14 | 1.27x |
| 2024-11-13 | 1.42x |
| 2024-11-12 | 1.49x |
| 2024-11-11 | 1.50x |
| 2024-11-08 | 0.68x |
| 2024-11-07 | 0.77x |
| 2024-11-06 | 0.91x |
| 2024-11-05 | 0.82x |
| 2024-11-04 | 0.75x |
| 2024-11-01 | 0.65x |
| 2024-10-31 | 1.10x |
| 2024-10-30 | 0.56x |
| 2024-10-29 | 0.58x |
| 2024-10-28 | 0.84x |
| 2024-10-25 | 0.22x |
| 2024-10-24 | 0.51x |
| 2024-10-23 | 0.51x |
| 2024-10-22 | 0.61x |
| 2024-10-21 | 0.57x |
| 2024-10-18 | 0.63x |
| 2024-10-17 | 0.73x |
| 2024-10-16 | 0.79x |
| 2024-10-15 | 0.76x |
| 2024-10-14 | 0.77x |
| 2024-10-11 | 0.77x |
| 2024-10-10 | 0.76x |
| 2024-10-09 | 0.80x |
| 2024-10-08 | 0.79x |
| 2024-10-07 | 0.75x |
| 2024-10-04 | 0.78x |
| 2024-10-03 | 0.74x |
| 2024-10-02 | 0.74x |
| 2024-10-01 | 0.76x |
| 2024-09-30 | 0.79x |
| 2024-09-27 | 0.79x |
| 2024-09-26 | 0.76x |
| 2024-09-25 | 0.74x |
| 2024-09-24 | 0.82x |
| 2024-09-23 | 0.79x |
| 2024-09-20 | 0.91x |
| 2024-09-19 | 0.93x |
| 2024-09-18 | 1.04x |
| 2024-09-17 | 1.11x |
| 2024-09-16 | 1.30x |
| 2024-09-13 | 1.38x |
| 2024-09-12 | 1.48x |
| 2024-09-11 | 1.48x |
| 2024-09-10 | 1.54x |
| 2024-09-09 | 1.51x |
| 2024-09-06 | 1.32x |
| 2024-09-05 | 1.52x |
| 2024-09-04 | 1.62x |
| 2024-09-03 | 1.13x |
| 2024-08-30 | 0.98x |
| 2024-08-29 | 0.72x |
| 2024-08-28 | 0.73x |
| 2024-08-27 | 0.76x |
| 2024-08-26 | 0.77x |
| 2024-08-23 | 0.77x |
| 2024-08-22 | 0.81x |
| 2024-08-21 | 0.85x |
| 2024-08-20 | 0.87x |
| 2024-08-19 | 0.87x |
| 2024-08-16 | 0.86x |
| 2024-08-15 | 0.85x |
| 2024-08-14 | 0.82x |
| 2024-08-13 | 0.48x |
| 2024-08-12 | 0.45x |
| 2024-08-09 | 0.59x |
| 2024-08-08 | 0.53x |
| 2024-08-07 | 0.51x |
| 2024-08-06 | 0.62x |
| 2024-08-05 | 0.61x |
| 2024-08-02 | 0.77x |
| 2024-08-01 | 1.25x |
| 2024-07-31 | 1.30x |
| 2024-07-30 | 1.32x |
| 2024-07-29 | 1.54x |
| 2024-07-26 | 1.78x |
| 2024-07-25 | 1.58x |
| 2024-07-24 | 1.50x |
| 2024-07-23 | 1.58x |
| 2024-07-22 | 2.28x |
| 2024-07-19 | 2.02x |
| 2024-07-18 | 1.90x |
| 2024-07-17 | 1.64x |
| 2024-07-16 | 1.32x |
| 2024-07-15 | 1.96x |
| 2024-07-12 | 0.43x |
| 2024-07-11 | 0.35x |
| 2024-07-10 | 0.28x |
| 2024-07-09 | 0.26x |
| 2024-07-08 | 0.26x |
| 2024-07-05 | 0.47x |
| 2024-07-03 | 0.48x |
| 2024-07-02 | 1.07x |
| 2024-07-01 | 1.09x |
| 2024-06-28 | 1.11x |
| 2024-06-27 | 1.21x |
| 2024-06-26 | 1.14x |
| 2024-06-25 | 1.18x |
| 2024-06-24 | 1.27x |
| 2024-06-21 | 1.30x |
| 2024-06-20 | 1.50x |
| 2024-06-18 | 1.44x |
| 2024-06-17 | 1.90x |
| 2024-06-14 | 2.12x |
| 2024-06-13 | 2.28x |
| 2024-06-12 | 2.02x |
| 2024-06-11 | 1.54x |
| 2024-06-10 | 1.68x |
| 2024-06-07 | 1.94x |
| 2024-06-06 | 2.80x |
| 2024-06-05 | 3.16x |
| 2024-06-04 | 3.10x |
| 2024-06-03 | 3.28x |
